ITC Limited's Amalgamation Scheme Effective June 1, 2026, with Sresta & Wimco
ITC Limited's amalgamation scheme for Sresta Natural Bioproducts and Wimco Limited is effective from June 1, 2026. The scheme has been sanctioned by the NCLT, with appointed dates of June 13, 2025 (Sresta) and April 1, 2025 (Wimco). Upon dissolution, Sresta’s UAE and USA subsidiaries will become wholly owned by ITC.
The amalgamation of subsidiaries and their subsequent dissolution, along with the direct ownership of Sresta's international subsidiaries, represents a significant corporate restructuring that can impact the company's operational structure and financial reporting.
The announcement is a procedural update regarding an amalgamation scheme that has been sanctioned and is becoming effective. It does not contain new financial information or performance indicators that would suggest a positive or negative sentiment.
ITC Limited has announced that the Scheme of Amalgamation of Sresta Natural Bioproducts Private Limited (Sresta) and Wimco Limited (Wimco) with the Company has been sanctioned by the Hon’ble National Company Law Tribunal, Kolkata and Hyderabad Benches.
Certified copies of the Orders were filed today with the Registrar of Companies, West Bengal, and Telangana, respectively. All conditions specified in Clause 30.1 of the Scheme have been fulfilled. The Appointed Date for Sresta is 13th June, 2025, and for Wimco is 1st April, 2025. The Effective Date of the Scheme is set for 1st June, 2026.
Effective from 1st June, 2026, Sresta and Wimco will be dissolved without winding up and will cease to be subsidiaries of ITC Limited. Consequently, Sresta’s two subsidiaries, Sresta Global FZE, UAE, and Fyve Elements LLC, USA, will become direct wholly owned subsidiaries of ITC Limited.
What to do with a filing like this
ITC Limited filed this with the NSE as a statutory disclosure, categorised under amalgamation. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by ITC Limited. Read the original for the full detail.